Intravenous cefiderocol for neurosurgical meningitis from an extensively drug-resistant New-Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa strain-Reference-Cited by-同舟云学术

Intravenous cefiderocol for neurosurgical meningitis from an extensively drug-resistant New-Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa strain

Published:2023-03 Issue: Volume:32 Page:29-30
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Stevenson Daniel R.^ORCID,Cherian Benny P.,Kinzig Martina^ORCID,Sörgel Fritz,Wareham David W

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference6 articles.

1. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes;Lautenbach;Infect Control Hosp Epidemiol,2010

2. Epidemiology and characteristics of metallo-β-Lactamase-producing Pseudomonas aeruginosa;Hong;Infect Chemother,2015

3. Dominance of international 'high-risk clones' among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK;Wright;J Antimicrob Chemother,2015

4. Cefiderocol: a novel agent for the management of multidrug-resistant Gram-negative organisms;Wu;Infect Dis Ther,2020

5. Molecular characterization of multidrug-resistant Pseudomonas aeruginosa isolates in hospitals in Myanmar;Tada;Antimicrob Agents Chemother,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ventriculitis por Pseudomonas aeruginosa multirresistente (MDR) asociada a drenaje ventricular externo;Medicina Clínica;2024-08

2. Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art;Antibiotics;2024-05-16

3. New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections;Antibiotics;2024-01-07

4. Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic;Infection and Drug Resistance;2023-06